RankAlpha logo
Back to Rankings

CUE

Cue BiopharmaF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
CUE vs peer average
33/100
CUE vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MRKR is the first available peer comparator.

Marker Therapeutics is the closest small-cap oncology development peer in the packet because valuation is similarly driven by clinical-platform optionality, balance-sheet durability, and financing sensitivity rather than commercial revenue.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMRKRMarker Therapeutics
CUE
Cue Biopharma
MRKR
Marker Therapeutics
Grade
F
D
Momentum
41
74
Value
41
41
Sentiment
0
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs MRKR

CUE / MRKR
Grade Position
Below peers
CUE vs. peer average (F vs. D)
33/100
Momentum
41
MRKR
Value
41
CUE
Sentiment
0
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CUE
1
MRKR
MRKR
D
40/100
-1
2
SNTI
SNTI
F
20/100
Even
3
BRNS
BRNS
D
40/100
-1
4
ORMP
Oramed Pharmaceuticals Inc Common
F
20/100
Even
5
ABOS
Acumen Pharmaceuticals Inc Common
D
40/100
-1
MRKR is the first peer returned for this comparison set.